Some Uncertainty Ahead For Towa Following Strong Financial Year

NHI Impact And Sunsho Acquisition Both Present Potential Risks

 
• By Chloe Kent

Towa performed well during the financial year ended 31 March, delivering a ¥15.9bn profit, but questions remain about the impact of Japan’s NHI drug price revision and its acquisition of Sunsho Pharmaceuticals going forward.

Businessman stood at crossroads
It remains to be seen whether Towa's Sunsho acquisition will prove itself a success • Source: Shutterstock

More from Earnings

More from Business